Documents filed this week in a federal whistleblower lawsuit against some of the nation's top spine surgeons hint at a lucrative financial relationship between Medtronic Inc. and several doctors at Twin Cities Spine Center, a Minneapolis practice that is one of the largest of its kind in the country.
The whistleblower suit alleges that the Fridley-based medical technology company offered consulting and royalty agreements to induce doctors to use its innovative bone-graft product, Infuse, in ways not approved by the U.S. Food and Drug Administration (FDA).
Seven doctors at Twin Cities Spine are named in the suit, which was filed by two former Medtronic employees in U.S. District Court in Boston. |